Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells (vol 1, pg 100003, 2020)

被引：0
|
作者：
Reighard, Seth D.
Cranert, Stacey A.
Rangel, Kelly M.
Ali, Ayad
Gyurova, Ivayla E.
de la Cruz-Lynch, Arthur T.
Tuazon, Jasmine A.
Khodoun, Marat V.
Kottyan, Leah C.
Smith, David F.
Brunner, Hermine I.
Waggoner, Stephen N.
机构：
来源：
CELL REPORTS MEDICINE | 2020年 / 1卷 / 05期
关键词：
D O I：
10.1016/j.xcrm.2020.100080
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells
    Reighard, Seth D.
    Cranert, Stacey A.
    Rangel, Kelly M.
    Ali, Ayad
    Gyurova, Ivayla E.
    de la Cruz-Lynch, Arthur T.
    Tuazon, Jasmine A.
    Khodoun, Marat, V
    Kottyan, Leah C.
    Smith, David F.
    Brunner, Hermine, I
    Waggoner, Stephen N.
    CELL REPORTS MEDICINE, 2020, 1 (01)
  • [2] Functional Chimeric Antigen Receptor-Expressing Natural Killer Cells Derived From Human Pluripotent Stem Cells
    Hermanson, David L.
    Ni, Zhenya
    Knorr, David A.
    Bendzick, Laura
    Pribyl, Lee J.
    Geller, Melissa
    Kaufman, Dan S.
    BLOOD, 2013, 122 (21)
  • [3] Targeting of folate receptor β on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells
    Lynn, Rachel C.
    Poussin, Mathilde
    Kalota, Anna
    Feng, Yang
    Low, Philip S.
    Dimitrov, Dimiter S.
    Powell, Daniel J., Jr.
    BLOOD, 2015, 125 (22) : 3466 - 3476
  • [4] Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
    Mehta, Rohtesh S.
    Rezvani, Katayoun
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [5] Design and development of therapies using chimeric antigen receptor-expressing T cells
    Dotti, Gianpietro
    Gottschalk, Stephen
    Savoldo, Barbara
    Brenner, Malcolm K.
    IMMUNOLOGICAL REVIEWS, 2014, 257 (01) : 107 - 126
  • [6] Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoprotein (vol 126, pg 629, 2015)
    Qin, H.
    Cho, M.
    Haso, W.
    BLOOD, 2016, 128 (10) : 1441 - 1441
  • [7] Novel chimeric antigen receptor-expressing T cells targeting the malignant mesothelioma-specific antigen sialylated HEG1
    Kouro, Taku
    Higashijima, Naoko
    Horaguchi, Shun
    Mano, Yasunobu
    Kasajima, Rika
    Xiang, Huihui
    Fujimoto, Yuki
    Kishi, Hiroyuki
    Hamana, Hiroshi
    Hoshino, Daisuke
    Himuro, Hidetomo
    Matsuura, Rieko
    Tsuji, Shoutaro
    Imai, Kohzoh
    Sasada, Tetsuro
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (10) : 1828 - 1841
  • [8] Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
    Thangaraj, Jaya Lakshmi
    Kaufman, Dan S.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2025, (216):
  • [9] Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoprotein
    Qin, Haiying
    Cho, Monica
    Haso, Waleed
    Zhang, Ling
    Tasian, Sarah K.
    Oo, Htoo Zarni
    Negri, Gian Luca
    Lin, Yongshun
    Zou, Jizhong
    Mallon, Barbara S.
    Maude, Shannon
    Teachey, David T.
    Barrett, David M.
    Orentas, Rimas J.
    Daugaard, Mads
    Sorensen, Poul H. B.
    Grupp, Stephan A.
    Fry, Terry J.
    BLOOD, 2015, 126 (05) : 629 - 639
  • [10] Engineered chimeric antigen receptor-expressing T cells for the treatment of pancreatic ductal adenocarcinoma
    Beatty, Gregory L.
    ONCOIMMUNOLOGY, 2014, 3 (04):
12345